Cancer Research Landon Prizes for Basic and Translational Cancer Research  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 49, 2898-2904, June 1, 1989]
© 1989 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Anzano, M. A.
Right arrow Articles by Greig, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Anzano, M. A.
Right arrow Articles by Greig, R.

Growth Factor Production by Human Colon Carcinoma Cell Lines

Mario A. Anzano1, David Rieman, William Prichett, Daniel F. Bown-Pope and Russell Greig

Department of Cell Biology [M. A. A., D. R., W. P., R. G.], Smith Kline & French Laboratories, King of Prussia, Pennsylvania 19406, and Department of Pathology [D. B-P.], University of Washington, Seattle, Washington 98195

Conditioned media collected under serum-free conditions over 24 to 48 h from 18 human colon adenocarcinoma cell lines were analyzed for transforming growth factor, types {alpha} and ß (TGF-{alpha} and -ß), and platelet-derived growth factor in assays for anchorage-independent growth and radioreceptor competition. Detectable levels of TGF-{alpha}, TGF-ß, and platelet-derived growth factor were produced by 17, 16, and 6 cell lines, respectively. Three liters of conditioned medium from highly tumorigenic (HT-29, DLD-1, and SW620) and nontumorigenic (SKCO-1) colon cell lines and from nonneoplastic rat kidney (NRK-52E) and small intestinal (IEC-6) epithelial cells were purified by high-performance liquid chromatography and assayed for TGF-{alpha}- and TGF-ß-like activity. The highly tumorigenic colon cell lines produced 10- to 45-fold (soft agar), 19- to 90-fold (radioreceptor), and 4- to 35-fold (radioimmunoassay) more TGF-{alpha} activity compared to the nonneoplastic rat intestinal (IEC) epithelial cells. NRK-52E did not produce detectable TGF-{alpha} activity. Radio-immunoassay analysis of peak fractions revealed only TGF-{alpha} immuno-reactivity; epidermal growth factor was not detected. Levels of TGF-ß-like material in the colon carcinoma populations were comparable (HT-29) or elevated (DLD-1, SW620) only 3- to 4-fold (soft agar) or 1- to 3-fold (radioreceptor binding) compared to IEC cells or NRK-52E. Growth factor production is an ubiquitous property of colon carcinoma cell lines maintained in vitro and is consistent with this class of molecule, playing a contributory role in regulating cell growth.

1 To whom requests for reprints should be addressed, at Department of Cell Biology (L109), Smith Kline & French Laboratories, 709 Swedeland Road, King of Prussia, PA 19406.

Received 10/13/88. Revised 2/24/89. Accepted 3/ 7/89.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
M. Keese, R. J. Magdeburg, T. Herzog, T. Hasenberg, M. Offterdinger, R. Pepperkok, J. W. Sturm, and P. I. H. Bastiaens
Imaging Epidermal Growth Factor Receptor Phosphorylation in Human Colorectal Cancer Cells and Human Tissues
J. Biol. Chem., July 29, 2005; 280(30): 27826 - 27831.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. M. Grana, C. I. Sartor, and A. D. Cox
Epidermal Growth Factor Receptor Autocrine Signaling in RIE-1 Cells Transformed by the Ras Oncogene Enhances Radiation Resistance
Cancer Res., November 15, 2003; 63(22): 7807 - 7814.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
S. Kim, K. Bell, S. A. Mousa, and J. A. Varner
Regulation of Angiogenesis in Vivo by Ligation of Integrin {alpha}5{beta}1 with the Central Cell-Binding Domain of Fibronectin
Am. J. Pathol., April 1, 2000; 156(4): 1345 - 1362.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
R. Jaszewski, A. Khan, F. H. Sarkar, O. Kucuk, M. Tobi, A. Zagnoon, R. Dhar, J. Kinzie, and A. P. N. Majumdar
Folic acid inhibition of EGFR-mediated proliferation in human colon cancer cell lines
Am J Physiol Cell Physiol, December 1, 1999; 277(6): C1142 - C1148.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
A. J. Janecki, M. H. Montrose, C. M. Tse, F. S. de Medina, A. Zweibaum, and M. Donowitz
Development of an endogenous epithelial Na+/H+ exchanger (NHE3) in three clones of Caco-2 cells
Am J Physiol Gastrointest Liver Physiol, August 1, 1999; 277(2): G292 - G305.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Yamamoto, K. Fujihashi, K. Kawabata, J. R. McGhee, and H. Kiyono
A Mucosal Intranet: Intestinal Epithelial Cells Down-Regulate Intraepithelial, But Not Peripheral, T Lymphocytes
J. Immunol., March 1, 1998; 160(5): 2188 - 2196.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Rosen, M. L. Coll, A. Li, and J. Filmus
Transforming Growth Factor-alpha Prevents Detachment-induced Inhibition of c-Src Kinase Activity, Bcl-XL Down-regulation, and Apoptosis of Intestinal Epithelial Cells
J. Biol. Chem., September 28, 2001; 276(40): 37273 - 37279.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1989 by the American Association for Cancer Research.